FDA OKs 1st generic nasal spray of overdose reversal drug
U.S. regulators have approved the first generic nasal spray version of Narcan, a drug that reverses opioid overdoses.
The Food and Drug Administration on Friday OK'd naloxone spray from Israel's Teva Pharmaceuticals.
Naloxone has been sold as a nasal spray in the U.S. since 2016 under the brand name Narcan. Pharmacists can dispense it without a prescription. It is also sold as a generic or brand-name drug in automatic injectors, prefilled syringes and vials.
A pack of two Narcan nasal sprays cost about $130 to $150 without insurance. Teva didn't immediately provide the product's price or when it will be available; its offices were closed Friday.
More than 47,600 Americans died of opioid overdoses in 2017, a toll that has been rising for two decades.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Some frustrated by lack of public Memorial Day ceremony at Port Hudson...
Smaller display, same big impact at state capitol on Memorial Day
Man steals wallet, goes on illegal shopping spree in Gonzales
Busy Day for Krispy Kreme Reopening
Winds cause deadly structure collapse, one person killed
Southern baseball players meet for unofficial practice in Port Allen
Kenan Cooper is first from West Feliciana to swim collegialety
LSU rolls out new turf in Tiger Stadium overnight
LSU Coaches dish on latest with football team
New West Feliciana football coach unsure of when he'll meet his new...